205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.47%
Positive revenue growth while AVGO is negative. John Neff might see a notable competitive edge here.
1.64%
Gross profit growth at 75-90% of AVGO's 1.85%. Bill Ackman would demand operational improvements to match competitor gains.
3.82%
Positive EBIT growth while AVGO is negative. John Neff might see a substantial edge in operational management.
1.96%
Positive operating income growth while AVGO is negative. John Neff might view this as a competitive edge in operations.
0.82%
Positive net income growth while AVGO is negative. John Neff might see a big relative performance advantage.
0.53%
Positive EPS growth while AVGO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
1.08%
Positive diluted EPS growth while AVGO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.11%
Slight or no buybacks while AVGO is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
-0.11%
Dividend reduction while AVGO stands at 0.10%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
20.60%
OCF growth above 1.5x AVGO's 11.55%. David Dodd would confirm a clear edge in underlying cash generation.
-126.40%
Negative FCF growth while AVGO is at 11.37%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
80.64%
10Y revenue/share CAGR under 50% of AVGO's 821.12%. Michael Burry would suspect a lasting competitive disadvantage.
21.37%
5Y revenue/share CAGR under 50% of AVGO's 76.69%. Michael Burry would suspect a significant competitive gap or product weakness.
41.12%
3Y revenue/share CAGR at 75-90% of AVGO's 46.96%. Bill Ackman would expect new product strategies to close the gap.
152.14%
10Y OCF/share CAGR under 50% of AVGO's 1297.20%. Michael Burry would worry about a persistent underperformance in cash creation.
-17.56%
Negative 5Y OCF/share CAGR while AVGO is at 97.45%. Joel Greenblatt would question the firm’s operational model or cost structure.
-17.95%
Negative 3Y OCF/share CAGR while AVGO stands at 35.39%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
216.94%
Below 50% of AVGO's 1726.05%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
31.88%
Positive 5Y CAGR while AVGO is negative. John Neff might view this as a strong mid-term relative advantage.
25.88%
Below 50% of AVGO's 497.44%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
74.95%
Below 50% of AVGO's 399.62%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
61.29%
Positive 5Y equity/share CAGR while AVGO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
110.37%
Positive short-term equity growth while AVGO is negative. John Neff sees a strong advantage in near-term net worth buildup.
342.27%
Below 50% of AVGO's 2313.97%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
99.75%
5Y dividend/share CAGR at 50-75% of AVGO's 153.48%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
37.90%
3Y dividend/share CAGR 1.25-1.5x AVGO's 33.92%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
4.21%
Our AR growth while AVGO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
13.41%
We show growth while AVGO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
5.88%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.46%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
10.79%
Debt growth far above AVGO's 0.07%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
4.84%
R&D dropping or stable vs. AVGO's 9.79%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-2.74%
We cut SG&A while AVGO invests at 25.86%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.